FRANÇOIS LESCURE, GENERAL MANAGER OF INVECTYS SAS, TO PARTICIPATE IN THE ABBVIE PARTNERING DAY IN PARIS, FRANCE ON OCTOBER 4TH, 2022 Paris, France, September…
9th International Conference on HLA-G July 4th – 5th 2022 Fondation Singer-Polignac, 43 Avenue Georges Mandel, 75116 Paris Invectys will be…
Invectys to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference Houston, Texas, USA – January 6th, 2022 (GLOBE NEWSWIRE) –…
Houston, Texas, USA, Dec. 16, 2021 (GLOBE NEWSWIRE) — Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development…
Houston, Texas, USA, Sept. 07, 2021 (GLOBE NEWSWIRE) — Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the…
ASCO Annual Meeting 2021 June 4th – 8th 2021 Invectys will be participating in the online 2021 ASCO Annual Meeting. Although online, this landmark event…
AACR Annual Meeting 2021 April 10th – 15th 2021 Invectys was at the AACR’s Annual Meeting 2021. Although online, the AACR Annual Meeting still carried…
ESMO Immuno-Oncology Congress 2019 December 11th – 14th 2019 Palexpo, Geneva, Switzerland Invectys will be attending the 2019 ESMO Immuno-Oncology Congress. From…
